ACCC | Learn How LAG-3 Helps Tumors Evade the Immune System and Why Inhibiting It May Enhance Existing Immunotherapies
Learn How LAG-3 Helps Tumors Evade the Immune System and Why Inhibiting It May Enhance Existing Immunotherapies
Could targeting LAG-3 take cancer immunotherapy to the next level? Dr. Sabi Pabla and Dr. Eric Severson share insights on this promising immune biomarker in the latest Labcorp Perspectives: Oncology interview. Listen Here
Upcoming Events
ACCC 43rd National Oncology Conference
In Person October 21, 2026 at 8:00 AM EDT450 Summer St, Boston, MA 02210, USAOmni Boston Hotel at the Seaport, Boston
In Person Conference & ConventionOctober 3, 2026 at 7:30 AM EDT8787 Keystone Crossing, Indianapolis, IN, USASheraton Indianapolis Hotel at Keystone Crossing, Indianapolis
In Person Conference & ConventionOctober 15, 2026 at 5:30 PM PDT255 N Virginia St, Reno, NV, USAWhitney Peak Hotel Reno, Tapestry Collection by Hilton, Reno
